Should Patients Still Be Using Flash CGM? Navigating the Shift to Real-Time Monitoring

As diabetes technology continues to evolve, clinicians are increasingly faced with an important question: should patients still be using flash continuous glucose monitoring (CGM), or is it time to switch to real-time CGM? While flash CGM systems have significantly improved glucose monitoring and patient engagement over traditional fingerstick testing, real-time continuous glucose monitoring (rtCGM) offers additional features that may improve safety and day-to-day diabetes management.

The decision is not always simple. Many patients do well with flash CGM, while others may benefit from continuous glucose visibility, automated alerts, and remote monitoring options. Therefore, understanding which patients are most likely to benefit from transitioning to real-time CGM can help clinicians personalize care without overwhelming patients or practices.

Table of Contents

• Understanding Flash CGM and Real-Time CGM
• Identifying Patients Who May Benefit from Real-Time CGM
• Managing CGM Data in Clinical Practice
• Insurance Coverage and Future Considerations
• Conclusion
• FAQs

Understanding Flash CGM and Real-Time CGM

Flash CGM systems require users to scan a sensor to view glucose readings. These systems provide valuable trend information, historical glucose data, and a clearer picture of daily glucose patterns. However, they depend on patient action to retrieve the data.

In contrast, rtCGM devices automatically send glucose readings throughout the day and night. More importantly, many systems provide alerts for high and low glucose levels, including warnings before glucose reaches dangerous ranges.

This difference matters most for patients who experience hypoglycemia unawareness, overnight glucose drops, or significant glycemic variability. In these cases, real-time alerts may help patients respond sooner and avoid more serious events.

Additionally, remote monitoring features can support caregivers, parents, and care teams when appropriate. For older adults, patients living alone, or people at higher risk of severe hypoglycemia, this added visibility may provide meaningful reassurance.

Even so, flash CGM remains useful for many patients. Some people prefer fewer alerts, a simpler experience, or a system they already understand well. Therefore, the best choice depends on clinical risk, patient preference, and how the person uses glucose data in daily life.

Identifying Patients Who May Benefit from Real-Time CGM

Not every patient using flash CGM needs a change. Nevertheless, several clinical scenarios may indicate that a switch to real-time CGM could provide meaningful benefits.

Patients with recurrent hypoglycemia are often strong candidates. Automated glucose alerts can notify users before glucose levels fall too low, which may reduce both the frequency and severity of hypoglycemic episodes.

Similarly, patients with hypoglycemia unawareness may benefit from predictive alerts. Since these individuals may not feel symptoms until glucose is dangerously low, real-time glucose monitoring can add an important layer of safety.

People using intensive insulin therapy may also benefit from the shift to real-time CGM. Whether they have type 1 diabetes or insulin-treated type 2 diabetes, these patients often make multiple treatment decisions each day. Continuous glucose data can support more informed dosing, meal planning, and activity adjustments.

Patients who remain above target despite regular flash CGM use may also be appropriate candidates. In some cases, real-time glucose trends help reveal patterns that scans alone may miss.

However, patient readiness matters. Successful use of rtCGM depends on comfort with alerts, willingness to review trends, and the ability to respond to data without feeling overwhelmed. For that reason, clinicians should discuss expectations before recommending a device change.

Managing CGM Data in Clinical Practice

One common concern in primary care is the increased volume of data that comes with rtCGM. While continuous glucose data can be valuable, it can also create workflow challenges if the practice does not have a clear review process.

Fortunately, modern CGM platforms often summarize key metrics in easy-to-review reports. These may include time in range, glucose management indicator, hypoglycemia exposure, and glycemic variability.

Because of this, clinicians do not need to interpret every glucose reading. Instead, they can focus on patterns that point to medication issues, meal-related glucose spikes, overnight lows, or safety concerns.

Team-based workflows can also help. For example, a medical assistant, diabetes educator, or care coordinator may download reports, confirm device use, and flag concerning trends before the visit.

Patient education is equally important. Patients should know which alerts require immediate action and which trends can wait until a scheduled appointment. Otherwise, too many notifications may lead to alert fatigue.

In addition, clinicians should remind patients that CGM data supports decision-making but does not replace clinical judgment. Regular follow-up, medication review, and individualized care planning remain essential.

Insurance Coverage and Future Considerations

Insurance coverage remains a major factor influencing decisions about switching from flash CGM to real-time monitoring. Although access has expanded, eligibility requirements can still vary by payer, plan, and patient profile.

Many payers recognize the value of CGM for patients using insulin therapy. However, documentation may still be needed to support medical necessity, especially for patients with hypoglycemia risk, glycemic variability, or difficulty meeting glycemic goals.

Clinicians can help by documenting insulin use, glucose patterns, hypoglycemia history, and prior monitoring challenges. As a result, coverage requests may be stronger and easier to justify.

Technology trends also point toward broader use of real-time glucose data. Automated insulin delivery systems, remote patient monitoring programs, and digital coaching tools often depend on continuous data transmission.

As these tools become more common, patients currently using flash CGM may have more reasons to adopt real-time CGM. Still, newer technology is not automatically better for every patient.

Ultimately, the most effective CGM is the one the patient can use consistently, understand clearly, and apply safely in daily life.

Conclusion

The conversation surrounding the shift to real-time CGM reflects the continued evolution of diabetes technology and patient-centered care. Flash CGM remains a valuable option for many people, especially those who prefer simplicity and are achieving their goals.

However, transitioning to real-time CGM may offer important advantages for patients with hypoglycemia risk, intensive insulin regimens, glucose variability, or a need for remote monitoring. Automated alerts and continuous data transmission can help patients act sooner and give clinicians a fuller view of glucose patterns.

For clinicians, the goal is not simply to recommend the newest device. Instead, the goal is to match the monitoring tool to the patient’s risks, habits, preferences, and treatment plan.

FAQs

What is the main difference between flash CGM and real-time CGM?

Flash CGM requires the user to scan the sensor to view glucose data. Real-time CGM automatically sends glucose readings and can provide alerts for high or low glucose levels.

Who may benefit most from transitioning to real-time CGM?

Patients with recurrent hypoglycemia, hypoglycemia unawareness, intensive insulin therapy, major glucose variability, or a need for remote monitoring may benefit most.

Does real-time CGM replace routine diabetes visits?

No. Real-time CGM provides helpful data, but patients still need regular clinical follow-up, medication review, and individualized diabetes care.

Can primary care practices manage rtCGM data effectively?

Yes. Standardized reports, clear workflows, and team-based review processes can make CGM data easier to manage in routine practice.

Is real-time CGM covered by insurance?

Coverage varies by payer and patient eligibility. Documentation of insulin use, hypoglycemia risk, or glucose management challenges may help support coverage requests.

Disclaimer: This content is not medical advice. For any health issues, always consult a healthcare professional. In an emergency, call 911 or your local emergency services.